How next-generation sequencing will change the treatment of multiple myeloma
Overview of the CLL13 trial: replacing chemotherapy with venetoclax-containing regimens
Julia von Tresckow
An update on two trials evaluating venetoclax in subsets of CLL
Why use model systems for multiple myeloma research?
Enrique Ocio et al.
CAR T-cells and CRISPR: The future of AML treatment